Trials / Completed
CompletedNCT00689858
Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo
Clinical Trial to Assessment the PK/PD Characteristics and Safety After co-Administration of Cilostazol With Ginkgo Biloba or Placebo in Healthy Subject.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- SK Chemicals Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
TO assess the PK/PD effect of co-administerd Cilostazol with Ginkgo biloba or placebo, Phase I study in healthy Volunteers were designed
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cilostazol, Ginkgo biloba and placebo | dosing time |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2008-06-04
- Last updated
- 2009-01-13
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00689858. Inclusion in this directory is not an endorsement.